Effect of steroids on energy expenditure and substrate oxidation in women with Crohn's disease

American Journal of Gastroenterology

Volumn 97, Issue 11, 2002, Pages 2843-2849

  Al Jaouni, Rima ^a   Schneider, Stephane M ^a   Piche, Thierry ^a   Rampal, Patrick ^a   Hébuterne, Xavier ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; PREDNISONE; STEROID;

ADULT; ARTICLE; BODY COMPOSITION; CALORIMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENERGY EXPENDITURE; FATTY ACID OXIDATION; FEMALE; HUMAN; LOW FAT DIET; OBESITY; OXIDATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DIET; RESPIRATORY QUOTIENT; SUBSTRATE INDUCED RESPIRATION; WEIGHT GAIN;

EID: 0036841980     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2002.07032.x     Document Type: Article

References (40)

1. Ferguson A, Glen M, Ghosh S. Crohn's disease: Nutrition and nutritional therapy. Bailliere's Clin Gastroenterol 1998:12:93-114.
2. Rigaud D, Angel L, Cerf M, et al. Mechanisms of decreased food intake during weight in adult Crohn's disease patients without obvious malabsorption. Am J Clin Nutr 1994;60:775-81.
3. Royall D, Greenberg G, Allard J, et al. Total enteral nutrition support improves body composition of patients with active Crohn's disease. JPEN 1995;19:95-9.
4. Capristo E, Mingrone G, Addolorato G, et al. Metabolic features of inflammatory bowel disease in a remission phase of the disease activity. J Intern Med 1998;243:339-47.
5. Capristo E, Addolorato G, Mingrone G, et al. Effect of disease localization on the anthropometric and metabolic features of Crohn's disease. Am J Gastroenterol 1998;93:2411-9.
6. Kushner R, Schoeller D. Resting and total energy expenditure in patients with inflammatory bowel disease. Am J Clin Nutr 1991;53:161-5.
7. Stokes M, Hill G. Total energy expenditure in patients with Crohn's disease: Measurement by the combined body scan technique. JPEN 1993;17:3-7.
8. Chan A, Fleming C, O'Fallon W, et al. Estimated versus measured basal energy requirements in patients with Crohn's disease. Gastroenterology 1986;91:75-8.
9. Mingrone G, Esmeralda C, Greco A, et al. Elevated diet-induced thermogenesis and lipid oxidation rate in Crohn's disease. Am J Clin Nutr 1999;69:325-30.
10. Al-Jaouni R, Hébuterne X, Pouget I, Rampal P. Energy metabolism and substrate oxidation in patients with Crohn's disease. Nutrition 2000;16:173-8.
11. Schneeweiss B, Lochs H, Zauner C, et al. Energy and substrate metabolism in patients with active Crohn's disease. J Nutr 1999;129:844-8.
12. Mingrone G, Greco A, Benedetti G, et al. Increased resting lipid oxidation in Crohn's disease. Dig Dis Sci 1996;41:72-6.
13. Malchow H, Ewe K, Brandes J, et al. European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment. Gastroenterology 1984;86:249-66.
14. Summers R, Switz D, Sessions JJ, et al. National Cooperative Crohn's Disease Study: Results of drug treatment. Gastroenterology 1979;77:847-69.
15. Cortot A, Colombel J, Rutgeers P, et al. Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease. Gut 2001;48:186-90.
16. Friend D. Review article: Issues in oral administration of locally acting glucocorticosteroids for treatment of inflammatory bowel disease. Aliment Pharmacol Ther 1998;12:591-603.
17. Campieri M, Ferguson A, Doe W, et al. Oral budesonide is as effective as oral prednisolone in active Crohn's disease. Gut 1997;41:209-14.
18. Munkholm P, Langholz E, Davidsen M, et al. Frequency of glucocorticosteroid resistance and dependency in Crohn's disease. Gut 1994;35:360-2.
19. Mingrone G, Benedetti G, Capristo E, et al. Twenty-four-hour energy balance in Crohn's disease patients: Metabolic implications of steroids treatment. Am J Clin Nutr 1998;67:118-23.
20. Willox J, Corr J, Shaw J, et al. Prednisolone as an appetite stimulant in patients with cancer. BMJ 1984;288:27.
21. Tataranni P, Larson D, Snittker S, et al. Effects of glucocorticoids on energy metabolism and intake in humans. Am J Physiol 1996;271:E317-E25.
22. Chong P, Jung R, Scrimgeour C, et al. The effect of pharmacological dosages of glucocorticoids on free living total energy expenditure in man. Clin Endocrinol 1994;40:577-81.
23. Zoli G, Care M, Parazza M, et al. A randomized controlled study comparing elemental diet and steroid treatment in Crohn's disease. Aliment Pharmacol Ther 1997;11:735-40.
24. Horber F, Marsh H, Haymond M. Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans. Diabetes 1991;40:141-9.
25. Brillon D, Zheng B, Campbell R, et al. Effect of cortisol on energy expenditure and amino acid metabolism in humans. Am J Physiol 1995;268:E501-E13.
26. Roubenoff R, Roubenoff RA, Ward L, et al. Catabolic effects of high-dose corticosteroids persist despite therapeutic benefit in rheumatoid arthritis. Am J Clin Nutr 1990;52:1113-7.
27. Bernades P, Hecketsweiler P, Benozio M, et al. Proposal of a system of criteria for the diagnosis of inflammatory bowel diseases. Gastroenterol Clin Biol 1978;2:1047-54.
28. Best W, Becktel J, Singleton J. Rederived values of the eight coefficients of the Crohn's disease activity index (CDAI). Gastroenterology 1979;77:843-6.
29. Boulier A, Ficker J, Thomasset A, et al. Fat-free mass estimation by the two-electrode impedance method. Am J Clin Nutr 1990;52:581-5.
30. Hawk P. The Kjeldahl method. In: Hawk PB, Oser BL, Summerson WH, eds. Practical Physiological Chemistry, 13th Ed. Toronto: Blakiston, 1954:874-82.
31. Ben Porat M, Sideman S, Bursztein S. Energy metabolism rate equations for fasting and postabsorptive subjects. Am J Physiol 1983;244:R764-R9.
32. Ferrannini E. The theorical bases of indirect calorimetry: A review. Metabolism 1988;37:287-301.
33. Frayn K. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 1983;55:628-34.
34. Godfrey K. Comparing the means of several groups. N Engl J Med 1985;313:1450-6.
35. Rebuffe-Scrive M, Krotkiewski M, Elfverson J, et al. Muscle and adipose tissue morphology and metabolism in Cushing's syndrome. J Clin Endocrinol Metab 1988;67:1122-8.
36. Calle C, Sanchez-Casas P, Carranza M, et al. Binding and antilipolytic action of insulin in isolated adipocytes from cortisol-treated rats. Rex Esp Fisiol 1988;44:309-14.
37. Wolthers T, Hamberg O, Grofte T, et al. Effects of budesonide and prednisolone on hepatic kinetics for urea synthesis. J Hepatol 2000;33:549-54.
38. De Jonge L, Agoues I, Garrel D. Decreased thermogenic response to food with intragastric vs. oral feeding. Am J Physiol 1991;260:E238-E42.
39. Thiebaud D, Schutz Y, Acheson K, et al. Energy cost of glucose storage in human subjects during glucose-insulin infusion. Am J Physiol 1983;244:E216-E21.
40. Thiebaud D, Jequier E, Felber J, et al. Effect of long-chain triglyceride infusion on glucose metabolism in man. Metabolism 1982;31:1128-36.